Suggested Use: Take as directed by a healthcare professional
Similar to adults, serious side effects in pediatric studies were not significant
About 44% of users in the study mentioned at least one side effect, most commonly gastrointestinal problems
Compounded semaglutide is prepared by compounding pharmacies under specific regulatory frameworks and is not individually approved by the FDA
Future studies should focus on validating diagnostic thresholds, defining endotype-specific therapeutic strategies, and evaluating cost-effective approaches applicable across diverse health-care settings
Just the fact that the drug exists and that its being promoted and that its in the public consciousness has people thinking about portion control, where consumers are trading down on pack size, for sure, he emphasized